Covetrus
Carprieve®
(carprofen) Chewable Tablets
Carprieve® (carprofen) Chewable Tablets is a generic form of the most commonly prescribed NSAID for dogs worldwide with an excellent reputation for safety and efficacy. Carprofen remains the veterinarians' first choice for the relief of pain and inflammation associated with osteoarthritis (OA) and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
Target Species: Dogs
Product Attributes
-
Bioequivalent to the pioneer product, Rimadyl® (carprofen) Chewable Tablets
-
Less expensive than Rimadyl® Chewables, offering significant savings and improved clinic profit potential
-
Available in 25 mg, 75 mg and 100 mg strengths
-
Available in 30, 60 and 180 count bottles
IMPORTANT SAFETY INFORMATION: As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. These are usually mild, but may be serious. Dog owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for dogs on any medication, including Carprieve®. Use with other NSAIDs or corticosteroids should be avoided. See full product labeling for full product information.
-
Active Ingredient(s)
carprofen
-
Dosage Form and Description
A brown circular tablet with strengths (25, 75, or 100) embossed on one side and a single score line on the other side. The tablets can be divided into halves.
-
Indications
Carprieve is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Dosage and Administration
Always provide Client Information Sheet with prescription. Carefully consider the potential benefits and risk of CARPRIEVE and other treatment options before deciding to use CARPRIEVE. Use the lowest effective dose for the shortest duration consistent with individual response. The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Caplets are scored and dosage should be calculated in half-caplet increments but should not exceed the maximum daily recommended dose. Tablets can be halved by placing the tablet on a hard surface and pressing down on both sides of the score. These liver flavored Carprieve chewable tablets may be offered to the dog by hand or placed on food. If the dog does not willingly consume the tablets, they may be hand-administered (pilled) as with other oral tablet medications. Care should be taken to ensure that the dog consumes the complete dose.
-
Storage
Store at controlled room temperature, 68°-77°F (20°-25°C); excursions permitted 15°-30°C (59°-86°F). Use half-tablet within 30 days.
© 2023 Norbrook Laboratories Limited. The Norbrook logo and Carprieve are registered trademarks of Norbrook Laboratories Limited. Rimadyl is a registered trademark of Zoetis, Inc.
Order Carprieve® Chewables Today
Select your preferred distributor.
First Veterinary Supply
HSB Veterinary Supply, Inc.
Midwest Veterinary Supply
Penn Veterinary Supply
Victor Medical Co.
If you are a pet owner looking to purchase Carprieve® Chewable Tablets, please consult with your local veterinarian.
Prefer to speak directly to a member of our team?
Norbrook®, Inc.
We are open Mon - Fri 8:00am - 5:00pm CST
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.
